Veranova A CDMO that manages complexity with confidence

Veranova A CDMO that manages complexity with confidence

X

Digital content for Boehringer Ingelheim GmbH

BOEHRINGER INGELHEIM GMBH

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

1060 News

1060 News

APIs // Active Pharmaceutical Ingredients

110 APIs, 86 USDMF, 45 CEP/COS, 21 JDMF, 12 KDMF, 15 NDC API

DEVELOPMENTS

116 Drug(s) in Development

116 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

995 Dossiers, 295 FDA Orange Book, 342 Europe, 120 Canada, 86 Australia, 152 South Africa

INSPECTIONS & REGISTRATIONS

87 FDA, 33 EDQM, 3 GDUFA

Full View Screen

Full Screen View

Boehringer's profit up as Jardiance gains offset higher costs

Boehringer's profit up as Jardiance gains offset higher costs

REUTERS

30 Mar 2023

Heart failure approvals help BI, Lilly's Jardiance rake in $6.3B

Heart failure approvals help BI, Lilly's Jardiance rake in $6.3B

Kevin Dunleavy FIERCE PHARMA

29 Mar 2023

Boehringer Ingelheim reaches more patients than ever in 2022

Boehringer Ingelheim reaches more patients than ever in 2022

BUSINESSWIRE

29 Mar 2023

Enforcement Report - Week of March 29, 2023

Enforcement Report - Week of March 29, 2023

FDA

29 Mar 2023

Boehringer puts down $481M to pursue emerging cancer target

Boehringer puts down $481M to pursue emerging cancer target

Nick Paul Taylor FIERCE BIOTECH

28 Mar 2023

Covant and Boehringer Collaborate to Develop a Novel ADAR1 Inhibitor

Covant and Boehringer Collaborate to Develop a Novel ADAR1 Inhibitor

GLOBENEWSWIRE

28 Mar 2023

Health Canada approves first treatment for generalized pustular psoriasis flares

Health Canada approves first treatment for generalized pustular psoriasis flares

NEWSWIRE

24 Mar 2023

BMS, Boehringer and Roche top Ogilvy Health’s latest social media rankings

BMS, Boehringer and Roche top Ogilvy Health’s latest social media rankings

Beth Snyder Bulik ENDPTS

23 Feb 2023

NICE fails to recommend Boehringer Ingelheim and Lilly Alliance’s empagliflozin

NICE fails to recommend Boehringer Ingelheim and Lilly Alliance’s empagliflozin

PHARMATIMES

08 Feb 2023

Boehringer Ingelheim's Spevigo (Spesolimab) Approved In Europe

Boehringer Ingelheim's Spevigo (Spesolimab) Approved In Europe

EMA

08 Feb 2023

biophore-india-pharmaceuticals-pvt-ltd-m-2023-03-27

Access Virtual Booth

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Market Place

Home

Menu

Post Enquiry

Market Place

Search